Key result
Bibliometric analysis reveals familial HCM research predominantly focuses on pathogenesis, diagnosis, and complications.
Why the study?
Familial hypertrophic cardiomyopathy is an inherited cardiac disease that can underlie major cardiovascular events, making early identification essential to reduce sudden cardiac death.
This bibliometric analysis highlights that recent research on familial hypertrophic cardiomyopathy is predominantly centered around its pathogenesis, diagnostic approaches, and complications.
Research emphasis on pathogenesis and diagnosis cautions against assuming therapeutic advances; leaves open gaps in management outcome studies.
Familial hypertrophic cardiomyopathy (FHCM) is an inherited cardiac disease caused by mutations of sarcomere proteins and can be the underlining substrate for major cardiovascular events. Early identification and diagnosis of FHCM are essential to reduce sudden cardiac death. So, this paper summarized the current knowledge on FHCM, and displayed the analysis via bibliometrics method. The relevant literature on FHCM were screened searched via the Web of Science Core Collection database from 2012 to 2022. The literatures were was summarized and analyzed via the bibliometrics method analyzed via CiteSpace and VOSviewer according to topic categories, distribution of spatiotemporal omics and authors, as well as references. Since 2012, there are 909 research articles and reviews related to FHCM. The number of publication for the past 10 years have shown that the development of FHCM research has been steady, with the largest amount of literature in 2012. The most published papers were from the United States, followed by the United Kingdom and Italy. The University of London (63 papers) was the institution that published the most research articles, followed by Harvard University (45 papers) and University College London (45 papers). Keywords formed 3 clusters, focused on the pathogenesis of FHCM, the diagnosis of FHCM, FHCM complications, respectively. The bibliometric analysis and visualization techniques employed herein highlight key trends and focal points in the field, predominantly centered around FHCM's pathogenesis, diagnostic approaches, and its complications. These insights are instrumental in steering future research directions in this area.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2024) conducted a review in Familial hypertrophic cardiomyopathy (FHCM) (n=909). Bibliometric analysis was evaluated on Research trends and hotspots. Bibliometric analysis of 909 articles from 2012 to 2022 revealed that familial hypertrophic cardiomyopathy research is predominantly centered around its pathogenesis, diagnostic approaches, and complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: